Medicamen Biotech Financial Results

For FY Latest, Medicamen Biotech recorded Net Sales of ₹- crores.This figure helps in determining the company’s true revenue after deducting discounts, returns, and allowances from Gross sales.

The Operating Profit of Medicamen Biotech for FY Latest is ₹- crores. With this amount, one can assess the profits derived from the company’s core (or primary) operations, excluding interest and taxes.

In FY Latest, Medicamen Biotech posted a Profit Before Tax of ₹- croresIt helps to understand whether a company is efficient enough to manage its costs and generate income before eliminating taxes.

Medicamen Biotech recorded a Net Profit of ₹- crores in FY Latest. It is a key indicator of profitability as it gives a more accurate picture of a company’s financial health by considering all costs associated with the business.

The Face Value of Medicamen Biotech shares is -.It indicates the initial capital raised by the company by issuing shares. Face value can determine a stocks current market value at the time of dividends, bonuses, or stock splits.

In FY Latest, the PAT Margin of Medicamen Biotech is - %. This metric provides insights into the company's efficiency in generating profits after paying taxes.

Open a Demat Account with Anand Rathi using the following steps:

1. Enter your basic details in the form.
2. Upload ID proof, PAN card, and bank details.
3. Complete eKYC online.
4. Start investing in Medicamen Biotech using our TradeMobi App or Web Trading Platform.